BETER na hodgkinlymfoom: Nazorg op maat voor langetermijneffecten van de behandeling

Translated title of the contribution: The BETER survivorship care initiative for Hodgkin lymphoma: Tailored survivorship care for late effects of treatment

N. Dekker, Mars B. Van'T Veer, Namens het BETER-consortium, Berthe M.P. Aleman, Flora E. Van Leeuwen*, John M.M. Raemaekers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The Dutch BETER consortium has established a national care infrastructure for Hodgkin lymphoma survivors. 'BETER' [the Dutch word for 'better'] stands for Better care after Hodgkin lymphoma (HL): Evaluation of longterm Treatment Effects and screening Recommendations. The survivorship care focuses on longterm effects of HL treatment. Over 10,000 HL survivors who were treated in the period spanning 19652008 have been identified. As part of the survivorship care initiative, specific BETER outpatient clinics have been set up. A dedicated website, www.beternahodgkin.nl, provides HL survivors with relevant information. The stakeholders of the BETER survivorship care programme aim to achieve an improved healthy life expectancy for patients treated for HL.

Translated title of the contributionThe BETER survivorship care initiative for Hodgkin lymphoma: Tailored survivorship care for late effects of treatment
Original languageDutch
Article numberA9269
JournalNederlands Tijdschrift voor Geneeskunde
Volume160
Issue number5
Publication statusPublished - 18 Nov 2015

Fingerprint

Dive into the research topics of 'The BETER survivorship care initiative for Hodgkin lymphoma: Tailored survivorship care for late effects of treatment'. Together they form a unique fingerprint.

Cite this